(Q39122362)

9 September 2017

Interleukin receptor family member ST2 concentrations in patients following heart transplantation (English)

1 reference

9 September 2017

1

James L Januzzi

1 reference

9 September 2017

Benjamin D Horne

2

1 reference

9 September 2017

Stephanie A Moore

3

1 reference

9 September 2017

Oxana Galenko

4

1 reference

9 September 2017

Gregory L Snow

5

1 reference

9 September 2017

Kimberly D Brunisholz

6

1 reference

9 September 2017

Joseph B Muhlestein

7

1 reference

9 September 2017

Rami Alharethi

8

1 reference

9 September 2017

John F Carlquist

9

1 reference

9 September 2017

Deborah Budge

10

1 reference

9 September 2017

Kismet Rasmussen

11

1 reference

9 September 2017

Abdallah G Kfoury

12

1 reference

9 September 2017

5 April 2013

1 reference

9 September 2017

1 reference

9 September 2017

18

1 reference

9 September 2017

3

1 reference

9 September 2017

250-256

1 reference

ST2 is an inhibitor of interleukin 1 receptor and Toll-like receptor 4 signaling and maintains endotoxin tolerance

9 September 2017

1 reference

https://api.crossref.org/works/10.3109%2F1354750X.2013.773081

Increased levels of soluble ST2 protein and IgG1 production in patients with sepsis and trauma.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1354750X.2013.773081

Analytical and clinical evaluation of a novel high-sensitivity assay for measurement of soluble ST2 in human plasma--the Presage ST2 assay

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1354750X.2013.773081

Measurement of the interleukin family member ST2 in patients with acute dyspnea: results from the PRIDE (Pro-Brain Natriuretic Peptide Investigation of Dyspnea in the Emergency Department) study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1354750X.2013.773081

Report from a consensus conference on antibody-mediated rejection in heart transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1354750X.2013.773081

Soluble ST2 is a marker for acute cardiac allograft rejection.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1354750X.2013.773081

CD4 T cell-mediated cardiac allograft rejection requires donor but not host MHC class II.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1354750X.2013.773081

Characteristics of the novel interleukin family biomarker ST2 in patients with acute heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1354750X.2013.773081

Complementary roles for biomarkers of biomechanical strain ST2 and N-terminal prohormone B-type natriuretic peptide in patients with ST-elevation myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1354750X.2013.773081

IL-33 and ST2 comprise a critical biomechanically induced and cardioprotective signaling system

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1354750X.2013.773081

IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1354750X.2013.773081

Revision of the 1990 working formulation for the standardization of nomenclature in the diagnosis of heart rejection

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1354750X.2013.773081

Role of IL-4 and Th2 responses in allograft rejection and tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1354750X.2013.773081

Regulatory functions of self-restricted MHC class II allopeptide-specific Th2 clones in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1354750X.2013.773081

Role of 4-1BB in Allograft Rejection Mediated by CD8+ T Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1354750X.2013.773081

Serum soluble ST2: a potential novel mediator in left ventricular and infarct remodeling after acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1354750X.2013.773081

IL-33 prolongs murine cardiac allograft survival through induction of TH2-type immune deviation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1354750X.2013.773081

10.3109/1354750X.2013.773081

21 January 2018

Identifiers

DOI

1 reference

9 September 2017

1 reference